Scientists make breakthrough in the fight against a disease which, in just 10 years, has grown from affecting one in 10 Canadians to one in four.
Using new technology that probes how drugs act on cellular functions, UdeM researchers see how the frontline diabetes drug metformin alters the uptake of glucose.
A new study published in Nature Communications shows that a molecular symbiosis between BAP1 and ASXL2 proteins can suppress cancerous tumors.
In a new study, researchers at the IRIC and the University of Copenhagen suggest a new avenue for developing drugs against weight problems causing diabetes, heart disease and cancer.
Hôpital Maisonneuve-Rosemont acquires a state-of-the-art microscope for eye operations.
A study led by researchers at CHU Sainte-Justine and UdeM confirms that cannabis use is related to impaired and lasting effects on adolescent cognitive development.
According to an analysis of surveys in five countries done by researchers at UdeM and other institutions, women who work the night shift run a higher greater risk of developing breast cancer.
Led by UdeM professor Daniel Borsuk, surgeons at Hôpital Maisonneuve-Rosemont announce that four months after the operation, their 64-year-old patient can breathe properly, chew, smell and speak.
The multidisciplinary team is the only one from Canada at SensUs, an international student competition in the Netherlands.
A study involving 3,927 men in Greater Montreal found that drinking a beer every day over a long period is associated with an increased risk of aggressive prostate cancer.